{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:47:13Z","timestamp":1790423233517,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41581-026-01061-5","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:15:21Z","timestamp":1773231321000},"page":"499-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u2018Missing\u2019 disease-causing variants in Alport syndrome"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6813-0288","authenticated-orcid":false,"given":"Judy","family":"Savige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Bournazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-6030","authenticated-orcid":false,"given":"Tomoko","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryony A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-7129","authenticated-orcid":false,"given":"Julia","family":"Hoefele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0699-960X","authenticated-orcid":false,"given":"Mary","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","volume":"24","author":"J Savige","year":"2013","unstructured":"Savige, J. et al. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J. Am. Soc. Nephrol. 24, 364\u2013375 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/ki.2011.452","volume":"81","author":"J Temme","year":"2012","unstructured":"Temme, J. et al. Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int. 81, 779\u2013783 (2012).","journal-title":"Kidney Int."},{"key":"1061_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/CS20191276","volume":"134","author":"H Mabillard","year":"2020","unstructured":"Mabillard, H. & Sayer, J. A. SGLT2 inhibitors \u2014 a potential treatment for Alport syndrome. Clin. Sci. 134, 379\u2013388 (2020).","journal-title":"Clin. Sci."},{"key":"1061_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00467-018-4121-1","volume":"35","author":"J Savige","year":"2020","unstructured":"Savige, J. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members. Pediatr. Nephrol. 35, 59\u201366 (2020).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.kint.2018.02.027","volume":"94","author":"G Bullich","year":"2018","unstructured":"Bullich, G. et al. A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases. Kidney Int. 94, 363\u2013371 (2018).","journal-title":"Kidney Int."},{"key":"1061_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.kint.2023.05.006","volume":"104","author":"M Boisson","year":"2023","unstructured":"Boisson, M. et al. A wave of deep intronic mutations in X-linked Alport syndrome. Kidney Int. 104, 367\u2013377 (2023).","journal-title":"Kidney Int."},{"key":"1061_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.883","volume":"7","author":"T Yamamura","year":"2019","unstructured":"Yamamura, T. et al. Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndrome. Mol. Genet. Genomic Med. 7, e883 (2019).","journal-title":"Mol. Genet. Genomic Med."},{"key":"1061_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/ndt\/gfab019","volume":"37","author":"A Domingo-Gallego","year":"2022","unstructured":"Domingo-Gallego, A. et al. Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. Nephrol. Dial. Transpl. 37, 687\u2013696 (2022).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1061_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cge.13861","volume":"99","author":"J Boeckhaus","year":"2021","unstructured":"Boeckhaus, J. et al. Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial. Clin. Genet. 99, 143\u2013156 (2021).","journal-title":"Clin. Genet."},{"key":"1061_CR10","unstructured":"Nozu, K., Yamamura, T., Horinouchi, T. In: Adam, M. P. et al. (eds). GeneReviews. (University of Washington; 2025)."},{"key":"1061_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","volume":"85","author":"Y Hashimura","year":"2014","unstructured":"Hashimura, Y. et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV alpha5 chain. Kidney Int. 85, 1208\u20131213 (2014).","journal-title":"Kidney Int."},{"key":"1061_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ki.1995.163","volume":"47","author":"MC Gubler","year":"1995","unstructured":"Gubler, M. C. et al. Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int. 47, 1142\u20131147 (1995).","journal-title":"Kidney Int."},{"key":"1061_CR13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1046\/j.1523-1755.1999.00357.x","volume":"55","author":"FT van der Loop","year":"1999","unstructured":"van der Loop, F. T. et al. Identification of COL4A5 defects in Alport\u2019s syndrome by immunohistochemistry of skin. Kidney Int. 55, 1217\u20131224 (1999).","journal-title":"Kidney Int."},{"key":"1061_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1220637","volume":"10","author":"DG Bichet","year":"2023","unstructured":"Bichet, D. G. et al. Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study. Front. Med. 10, 1220637 (2023).","journal-title":"Front. Med."},{"key":"1061_CR15","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2215\/CJN.03120322","volume":"17","author":"J Savige","year":"2022","unstructured":"Savige, J. et al. Digenic Alport Syndrome. Clin. J. Am. Soc. Nephrol. 17, 1697\u20131706 (2022).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1061_CR16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1681\/ASN.0000000000000076","volume":"34","author":"F Becherucci","year":"2023","unstructured":"Becherucci, F. et al. A clinical workflow for cost-saving high-rate diagnosis of genetic kidney diseases. J. Am. Soc. Nephrol. 34, 706\u2013720 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1061_CR17","doi-asserted-by":"publisher","first-page":"994","DOI":"10.7326\/M21-4109","volume":"175","author":"W Burke","year":"2022","unstructured":"Burke, W., Parens, E., Chung, W. K., Berger, S. M. & Appelbaum, P. S. The challenge of genetic variants of uncertain clinical significance: a narrative review. Ann. Intern. Med. 175, 994\u20131000 (2022).","journal-title":"Ann. Intern. Med."},{"key":"1061_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"1061_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41525-023-00362-z","volume":"8","author":"Y Hort","year":"2023","unstructured":"Hort, Y. et al. Atypical splicing variants in PKD1 explain most undiagnosed typical familial ADPKD. NPJ Genom. Med. 8, 16 (2023).","journal-title":"NPJ Genom. Med."},{"key":"1061_CR20","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1007\/s00467-024-06299-4","volume":"39","author":"A Caliment","year":"2024","unstructured":"Caliment, A., Van Reeth, O., Hougardy, C., Dahan, K. & Niel, O. A step-by-step, multidisciplinary strategy to maximize the yield of genetic testing in pediatric patients with chronic kidney diseases. Pediatr. Nephrol. 39, 2733\u20132740 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR21","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","volume":"32","author":"J Gibson","year":"2021","unstructured":"Gibson, J. et al. Prevalence estimates of predicted pathogenic COL4A3\u2013COL4A5 variants in a population sequencing database and their implications for Alport syndrome. J. Am. Soc. Nephrol. 32, 2273\u20132290 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1061_CR22","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.ekir.2022.06.001","volume":"7","author":"J Savige","year":"2022","unstructured":"Savige, J. Heterozygous pathogenic COL4A3 and COL4A4 variants (autosomal dominant Alport syndrome) are common, and not typically associated with end-stage kidney failure, hearing loss, or ocular abnormalities. Kidney Int. Rep. 7, 1933\u20131938 (2022).","journal-title":"Kidney Int. Rep."},{"key":"1061_CR23","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s00467-022-05846-1","volume":"38","author":"J Shanks","year":"2023","unstructured":"Shanks, J., Butler, G., Cheng, D., Jayasinghe, K. & Quinlan, C. Clinical and diagnostic utility of genomic sequencing for children referred to a Kidney Genomics Clinic with microscopic haematuria. Pediatr. Nephrol. 38, 2623\u20132630 (2023).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/jamaophthalmol.2013.1452","volume":"131","author":"F Ahmed","year":"2013","unstructured":"Ahmed, F. et al. Temporal macular thinning associated with X-linked Alport syndrome. JAMA Ophthalmol. 131, 777\u2013782 (2013).","journal-title":"JAMA Ophthalmol."},{"key":"1061_CR25","doi-asserted-by":"publisher","unstructured":"Solanki, K. V. et al. The phenotypic spectrum of COL4A3 heterozygotes. Preprint at\u00a0medRxiv https:\/\/doi.org\/10.1101\/2023.04.11.23288298 (2023).","DOI":"10.1101\/2023.04.11.23288298"},{"key":"1061_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan, C. E. et al. Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. 93, 1045\u20131051 (2018).","journal-title":"Kidney Int."},{"key":"1061_CR27","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/genes13101779","volume":"13","author":"Y Hirabayashi","year":"2022","unstructured":"Hirabayashi, Y. et al. Mutation analysis of thin basement membrane nephropathy. Genes 13, 1779 (2022).","journal-title":"Genes"},{"key":"1061_CR28","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais, J. P. et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J. Am. Soc. Nephrol. 14, 2603\u20132610 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1061_CR29","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1053\/ajkd.2001.29217","volume":"38","author":"H Dagher","year":"2001","unstructured":"Dagher, H. et al. A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport\u2019s syndrome. Am. J. Kidney Dis. 38, 1217\u20131228 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"1061_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00467-024-06538-8","volume":"40","author":"NSL Ng","year":"2025","unstructured":"Ng, N. S. L., Yamamura, T., Shenoy, M., Stuart, H. M. & Lennon, R. Detection of Alport gene variants in children and young people with persistent haematuria. Pediatr. Nephrol. 40, 719\u2013729 (2025).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2215\/CJN.10581014","volume":"10","author":"J Savige","year":"2015","unstructured":"Savige, J. et al. Ocular features in Alport syndrome: pathogenesis and clinical significance. Clin. J. Am. Soc. Nephrol. 10, 703\u2013709 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1061_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/13816810.2017.1401088","volume":"39","author":"Y Chen","year":"2018","unstructured":"Chen, Y., Colville, D., Ierino, F., Symons, A. & Savige, J. Temporal retinal thinning and the diagnosis of Alport syndrome and thin basement membrane nephropathy. Ophthalmic Genet. 39, 208\u2013214 (2018).","journal-title":"Ophthalmic Genet."},{"key":"1061_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000424811","volume":"117","author":"CE Kashtan","year":"1996","unstructured":"Kashtan, C. E., Kleppel, M. M. & Gubler, M. C. Immunohistologic findings in Alport syndrome. Contrib. Nephrol. 117, 142\u2013153 (1996).","journal-title":"Contrib. Nephrol."},{"key":"1061_CR34","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","volume":"29","author":"J Savige","year":"2021","unstructured":"Savige, J. et al. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. Eur. J. Hum. Genet. 29, 1186\u20131197 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"1061_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161802","volume":"11","author":"J Savige","year":"2016","unstructured":"Savige, J. et al. X-linked and autosomal recessive Alport syndrome: pathogenic variant features and further genotype-phenotype correlations. PLoS ONE 11, e0161802 (2016).","journal-title":"PLoS ONE"},{"key":"1061_CR36","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41431-019-0440-3","volume":"27","author":"LM Baudhuin","year":"2019","unstructured":"Baudhuin, L. M., Kluge, M. L., Kotzer, K. E. & Lagerstedt, S. A. Variability in gene-based knowledge impacts variant classification: an analysis of FBN1 missense variants in ClinVar. Eur. J. Hum. Genet. 27, 1550\u20131560 (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"1061_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06525-9","volume":"12","author":"JT Gibson","year":"2022","unstructured":"Gibson, J. T. et al. Genotype-phenotype correlations for COL4A3\u2013COL4A5 variants resulting in Gly substitutions in Alport syndrome. Sci. Rep. 12, 2722 (2022).","journal-title":"Sci. Rep."},{"key":"1061_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","volume":"23","author":"E Nagy","year":"1998","unstructured":"Nagy, E. & Maquat, L. E. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem. Sci. 23, 198\u2013199 (1998).","journal-title":"Trends Biochem. Sci."},{"key":"1061_CR39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.kint.2020.06.038","volume":"98","author":"T Yamamura","year":"2020","unstructured":"Yamamura, T. et al. Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome. Kidney Int. 98, 1605\u20131614 (2020).","journal-title":"Kidney Int."},{"key":"1061_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.chembiol.2018.02.003","volume":"25","author":"K Omachi","year":"2018","unstructured":"Omachi, K. et al. A split-luciferase-based trimer formation assay as a high-throughput screening platform for therapeutics in Alport syndrome. Cell Chem. Biol. 25, 634\u2013643.e4 (2018).","journal-title":"Cell Chem. Biol."},{"key":"1061_CR41","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ekir.2020.01.008","volume":"5","author":"M Kamura","year":"2020","unstructured":"Kamura, M. et al. Trimerization and genotype-phenotype correlation of COL4A5 mutants in Alport syndrome. Kidney Int. Rep. 5, 718\u2013726 (2020).","journal-title":"Kidney Int. Rep."},{"key":"1061_CR42","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.34067\/KID.0005472022","volume":"3","author":"J Kohler","year":"2022","unstructured":"Kohler, J., Omachi, K., Charu, V., Miner, J. H. & Bhalla, V. A COL4A4-G394S variant and impaired collagen IV trimerization in a patient with mild Alport syndrome. Kidney 360 3, 1899\u20131908 (2022).","journal-title":"Kidney 360"},{"key":"1061_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1681\/ASN.0000000000000480","volume":"36","author":"F Lona-Durazo","year":"2025","unstructured":"Lona-Durazo, F. et al. Association of genetically predicted skipping of COL4A4 exon 27 with hematuria and albuminuria. J. Am. Soc. Nephrol. 36, 48\u201359 (2025).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1061_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2025.151651","volume":"45","author":"AR Chang","year":"2025","unstructured":"Chang, A. R. et al. Using large genomic biobanks to generate insights into genetic kidney disease. Semin. Nephrol. 45, 151651 (2025).","journal-title":"Semin. Nephrol."},{"key":"1061_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.ajkd.2019.12.008","volume":"76","author":"KM Riedhammer","year":"2020","unstructured":"Riedhammer, K. M. et al. Exome sequencing and identification of phenocopies in patients with clinically presumed hereditary nephropathies. Am. J. Kidney Dis. 76, 460\u2013470 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"1061_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0272-6386(99)70417-8","volume":"33","author":"F Scolari","year":"1999","unstructured":"Scolari, F. et al. Familial clustering of IgA nephropathy: further evidence in an Italian population. Am. J. Kidney Dis. 33, 857\u2013865 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"1061_CR47","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0272-6386(12)80106-5","volume":"18","author":"G Monga","year":"1991","unstructured":"Monga, G., Mazzucco, G. & Roccatello, D. The association of IgA glomerulonephritis and thin glomerular basement membrane disease in a hematuric patient: light and electron microscopic and immunofluorescence investigation. Am. J. Kidney Dis. 18, 409\u2013412 (1991).","journal-title":"Am. J. Kidney Dis."},{"key":"1061_CR48","volume-title":"In: StatPearls","year":"2025","unstructured":"Leslie, S. W., Sajjad, H. (eds). In: StatPearls. (StatPearls, 2025)."},{"key":"1061_CR49","first-page":"78","volume":"20","author":"DF Birch","year":"1983","unstructured":"Birch, D. F. et al. Urinary erythrocyte morphology in the diagnosis of glomerular hematuria. Clin. Nephrol. 20, 78\u201384 (1983).","journal-title":"Clin. Nephrol."},{"key":"1061_CR50","first-page":"1196","volume":"10","author":"B Serrano","year":"2025","unstructured":"Serrano, B. & Savige, J. Extrarenal clinical features are reported for most genes implicated in genetic kidney disease. Pediatr. Nephrol. 10, 1196\u20131204 (2025).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR51","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41431-022-01177-9","volume":"30","author":"B Popp","year":"2022","unstructured":"Popp, B. et al. Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study. Eur. J. Hum. Genet. 30, 1413\u20131422 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"1061_CR52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380, 142\u2013151 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1061_CR53","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/ndt\/gfae002","volume":"39","author":"T Bada-Bosch","year":"2024","unstructured":"Bada-Bosch, T. et al. Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome. Nephrol. Dial. Transpl. 39, 1288\u20131298 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1061_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-5-r51","volume":"14","author":"MG Ross","year":"2013","unstructured":"Ross, M. G. et al. Characterizing and measuring bias in sequence data. Genome Biol. 14, R51 (2013).","journal-title":"Genome Biol."},{"key":"1061_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44116-y","volume":"15","author":"B Mandiracioglu","year":"2024","unstructured":"Mandiracioglu, B. et al. ECOLE: Learning to call copy number variants on whole exome sequencing data. Nat. Commun. 15, 132 (2024).","journal-title":"Nat. Commun."},{"key":"1061_CR56","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.gene.2013.05.045","volume":"526","author":"S Beicht","year":"2013","unstructured":"Beicht, S. et al. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome. Gene 526, 474\u2013477 (2013).","journal-title":"Gene"},{"key":"1061_CR57","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/jmg.37.9.717","volume":"37","author":"M Bruttini","year":"2000","unstructured":"Bruttini, M. et al. Mosaicism in Alport syndrome with genetic counselling. J. Med. Genet. 37, 717\u2013719 (2000).","journal-title":"J. Med. Genet."},{"key":"1061_CR58","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/ndt\/gfn005","volume":"23","author":"RP Krol","year":"2008","unstructured":"Krol, R. P. et al. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome. Nephrol. Dial. Transpl. 23, 2525\u20132530 (2008).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1061_CR59","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/jmg.37.3.238","volume":"37","author":"KE Plant","year":"2000","unstructured":"Plant, K. E., Boye, E., Green, P. M., Vetrie, D. & Flinter, F. A. Somatic mosaicism associated with a mild Alport syndrome phenotype. J. Med. Genet. 37, 238\u2013239 (2000).","journal-title":"J. Med. Genet."},{"key":"1061_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s13730-020-00503-8","volume":"9","author":"Y Aoto","year":"2020","unstructured":"Aoto, Y. et al. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome. CEN Case Rep. 9, 431\u2013436 (2020).","journal-title":"CEN Case Rep."},{"key":"1061_CR61","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ajhg.2021.03.006","volume":"108","author":"R Truty","year":"2021","unstructured":"Truty, R. et al. Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation. Am. J. Hum. Genet. 108, 696\u2013708 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"1061_CR62","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/j.ajhg.2024.08.002","volume":"111","author":"PJ Sullivan","year":"2024","unstructured":"Sullivan, P. J., Quinn, J. M. W., Wu, W., Pinese, M. & Cowley, M. J. SpliceVarDB: a comprehensive database of experimentally validated human splicing variants. Am. J. Hum. Genet. 111, 2164\u20132175 (2024).","journal-title":"Am. J. Hum. Genet."},{"key":"1061_CR63","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ekir.2024.11.016","volume":"10","author":"H Kitakado","year":"2025","unstructured":"Kitakado, H. et al. COL4A5 intronic variants at third to fifth nucleotides cause Alport syndrome. Kidney Int. Rep. 10, 516\u2013521 (2025).","journal-title":"Kidney Int. Rep."},{"key":"1061_CR64","volume":"3","author":"SJ Bryen","year":"2022","unstructured":"Bryen, S. J. et al. Prevalence, parameters, and pathogenic mechanisms for splice-altering acceptor variants that disrupt the AG exclusion zone. HGG Adv. 3, 100125 (2022).","journal-title":"HGG Adv."},{"key":"1061_CR65","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1101\/gr.182899.114","volume":"25","author":"TR Mercer","year":"2015","unstructured":"Mercer, T. R. et al. Genome-wide discovery of human splicing branchpoints. Genome Res. 25, 290\u2013303 (2015).","journal-title":"Genome Res."},{"key":"1061_CR66","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41588-022-01293-8","volume":"55","author":"R Dawes","year":"2023","unstructured":"Dawes, R. et al. SpliceVault predicts the precise nature of variant-associated mis-splicing. Nat. Genet. 55, 324\u2013332 (2023).","journal-title":"Nat. Genet."},{"key":"1061_CR67","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1681\/ASN.2018030228","volume":"29","author":"T Horinouchi","year":"2018","unstructured":"Horinouchi, T. et al. Detection of splicing abnormalities and genotype-phenotype correlation in X-linked Alport syndrome. J. Am. Soc. Nephrol. 29, 2244\u20132254 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1061_CR68","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrg3051","volume":"12","author":"ZE Sauna","year":"2011","unstructured":"Sauna, Z. E. & Kimchi-Sarfaty, C. Understanding the contribution of synonymous mutations to human disease. Nat. Rev. Genet. 12, 683\u2013691 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"1061_CR69","doi-asserted-by":"publisher","first-page":"497","DOI":"10.34067\/KID.0005252021","volume":"3","author":"R Rossanti","year":"2022","unstructured":"Rossanti, R. et al. Evaluation of suspected autosomal Alport syndrome synonymous variants. Kidney 360 3, 497\u2013505 (2022).","journal-title":"Kidney 360"},{"key":"1061_CR70","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ekir.2021.10.012","volume":"7","author":"Y Aoto","year":"2022","unstructured":"Aoto, Y. et al. Last nucleotide substitutions of COL4A5 exons cause aberrant splicing. Kidney Int. Rep. 7, 108\u2013116 (2022).","journal-title":"Kidney Int. Rep."},{"key":"1061_CR71","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.ajhg.2022.10.016","volume":"109","author":"RS Dhindsa","year":"2022","unstructured":"Dhindsa, R. S. et al. A minimal role for synonymous variation in human disease. Am. J. Hum. Genet. 109, 2105\u20132109 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"1061_CR72","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s10157-022-02294-x","volume":"27","author":"E Okada","year":"2023","unstructured":"Okada, E. et al. Aberrant splicing caused by exonic single nucleotide variants positioned 2nd or 3rd to the last nucleotide in the COL4A5 gene. Clin. Exp. Nephrol. 27, 218\u2013226 (2023).","journal-title":"Clin. Exp. Nephrol."},{"key":"1061_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-3306-3","volume":"20","author":"R Wang","year":"2019","unstructured":"Wang, R., Wang, Z., Wang, J. & Li, S. SpliceFinder: ab initio prediction of splice sites using convolutional neural network. BMC Bioinforma. 20, 652 (2019).","journal-title":"BMC Bioinforma."},{"key":"1061_CR74","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1093\/bioinformatics\/bty497","volume":"34","author":"J Zuallaert","year":"2018","unstructured":"Zuallaert, J. et al. SpliceRover: interpretable convolutional neural networks for improved splice site prediction. Bioinformatics 34, 4180\u20134188 (2018).","journal-title":"Bioinformatics"},{"key":"1061_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53088-6","volume":"15","author":"N You","year":"2024","unstructured":"You, N. et al. SpliceTransformer predicts tissue-specific splicing linked to human diseases. Nat. Commun. 15, 9129 (2024).","journal-title":"Nat. Commun."},{"key":"1061_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02664-4","volume":"23","author":"T Zeng","year":"2022","unstructured":"Zeng, T. & Li, Y. I. Predicting RNA splicing from DNA sequence using Pangolin. Genome Biol. 23, 103 (2022).","journal-title":"Genome Biol."},{"key":"1061_CR77","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.ajhg.2021.06.014","volume":"108","author":"D Danis","year":"2021","unstructured":"Danis, D. et al. Interpretable prioritization of splice variants in diagnostic next-generation sequencing. Am. J. Hum. Genet. 108, 1564\u20131577 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"1061_CR78","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1002\/humu.24491","volume":"43","author":"R Leman","year":"2022","unstructured":"Leman, R. et al. SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing. Hum. Mutat. 43, 2308\u20132323 (2022).","journal-title":"Hum. Mutat."},{"key":"1061_CR79","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting splicing from primary sequence with deep learning. Cell 176, 535\u2013548.e24 (2019).","journal-title":"Cell"},{"key":"1061_CR80","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/acn3.52041","volume":"11","author":"RG Marchant","year":"2024","unstructured":"Marchant, R. G. et al. Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone. Ann. Clin. Transl. Neurol. 11, 1250\u20131266 (2024).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1061_CR81","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"110","author":"LC Walker","year":"2023","unstructured":"Walker, L. C. et al. Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI Splicing Subgroup. Am. J. Hum. Genet. 110, 1046\u20131067 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"1061_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6363-0","volume":"19","author":"M Marczyk","year":"2019","unstructured":"Marczyk, M. et al. The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues. BMC Cancer 19, 1189 (2019).","journal-title":"BMC Cancer"},{"key":"1061_CR83","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ekir.2023.04.001","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Wang, X., Zhou, J., Ding, J. & Wang, F. Abnormal mRNA splicing effect of COL4A3 to COL4A5 unclassified variants. Kidney Int. Rep. 8, 1399\u20131406 (2023).","journal-title":"Kidney Int. Rep."},{"key":"1061_CR84","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1093\/bioinformatics\/btaa259","volume":"36","author":"G Jenkinson","year":"2020","unstructured":"Jenkinson, G. et al. LeafCutterMD: an algorithm for outlier splicing detection in rare diseases. Bioinformatics 36, 4609\u20134615 (2020).","journal-title":"Bioinformatics"},{"key":"1061_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36585-y","volume":"14","author":"J Vaquero-Garcia","year":"2023","unstructured":"Vaquero-Garcia, J. et al. RNA splicing analysis using heterogeneous and large RNA-seq datasets. Nat. Commun. 14, 1230 (2023).","journal-title":"Nat. Commun."},{"key":"1061_CR86","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.ajhg.2023.10.014","volume":"110","author":"IF Scheller","year":"2023","unstructured":"Scheller, I. F., Lutz, K., Mertes, C., Yepez, V. A. & Gagneur, J. Improved detection of aberrant splicing with FRASER 2.0 and the intron Jaccard index. Am. J. Hum. Genet. 110, 2056\u20132067 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"1061_CR87","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41596-020-00462-5","volume":"16","author":"VA Yepez","year":"2021","unstructured":"Yepez, V. A. et al. Detection of aberrant gene expression events in RNA sequencing data. Nat. Protoc. 16, 1276\u20131296 (2021).","journal-title":"Nat. Protoc."},{"key":"1061_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48990-9","volume":"9","author":"T Horinouchi","year":"2019","unstructured":"Horinouchi, T. et al. Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay. Sci. Rep. 9, 12696 (2019).","journal-title":"Sci. Rep."},{"key":"1061_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1342","volume":"8","author":"T Horinouchi","year":"2020","unstructured":"Horinouchi, T. et al. Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay. Mol. Genet. Genomic Med. 8, e1342 (2020).","journal-title":"Mol. Genet. Genomic Med."},{"key":"1061_CR90","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41525-023-00373-w","volume":"8","author":"ES Singer","year":"2023","unstructured":"Singer, E. S. et al. The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death. NPJ Genom. Med. 8, 29 (2023).","journal-title":"NPJ Genom. Med."},{"key":"1061_CR91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2023.11.005","volume":"111","author":"DM Fowler","year":"2024","unstructured":"Fowler, D. M. & Rehm, H. L. Will variants of uncertain significance still exist in 2030? Am. J. Hum. Genet. 111, 5\u201310 (2024).","journal-title":"Am. J. Hum. Genet."},{"key":"1061_CR92","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","volume":"36","author":"CE Kashtan","year":"2021","unstructured":"Kashtan, C. E. & Gross, O. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults \u2014 an update for 2020. Pediatr. Nephrol. 36, 711\u2013719 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR93","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1016\/j.ekir.2024.09.014","volume":"9","author":"J Boeckhaus","year":"2024","unstructured":"Boeckhaus, J. et al. SGLT2-Inhibition in patients with Alport syndrome. Kidney Int. Rep. 9, 3490\u20133500 (2024).","journal-title":"Kidney Int. Rep."},{"key":"1061_CR94","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/ckj\/sfac195","volume":"16","author":"H Bakis","year":"2023","unstructured":"Bakis, H. et al. Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study. Clin. Kidney J. 16, 100\u2013110 (2023).","journal-title":"Clin. Kidney J."},{"key":"1061_CR95","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.ekir.2020.09.042","volume":"5","author":"C Izzi","year":"2020","unstructured":"Izzi, C. et al. Variable expressivity of HNF1B nephropathy, from renal cysts and diabetes to medullary sponge kidney through tubulo-interstitial kidney disease. Kidney Int. Rep. 5, 2341\u20132350 (2020).","journal-title":"Kidney Int. Rep."},{"key":"1061_CR96","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.kint.2023.07.021","volume":"104","author":"LR Claus","year":"2023","unstructured":"Claus, L. R. et al. Certain heterozygous variants in the kinase domain of the serine\/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease. Kidney Int. 104, 995\u20131007 (2023).","journal-title":"Kidney Int."},{"key":"1061_CR97","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","volume":"109","author":"SR Senum","year":"2022","unstructured":"Senum, S. R. et al. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am. J. Hum. Genet. 109, 136\u2013156 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"1061_CR98","unstructured":"ClinGen. Alport Syndrome Variant Curation Expert Panel. https:\/\/clinicalgenome.org\/affiliation\/50146\/."},{"key":"1061_CR99","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00467-023-06068-9","volume":"39","author":"J Virth","year":"2024","unstructured":"Virth, J., Mack, H. G., Colville, D., Crockett, E. & Savige, J. Ocular manifestations of congenital anomalies of the kidney and urinary tract (CAKUT). Pediatr. Nephrol. 39, 357\u2013369 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR100","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/13816810.2023.2253901","volume":"44","author":"G Yang","year":"2023","unstructured":"Yang, G., Mack, H., Harraka, P., Colville, D. & Savige, J. Ocular manifestations of the genetic renal tubulopathies. Ophthalmic Genet. 44, 515\u2013529 (2023).","journal-title":"Ophthalmic Genet."},{"key":"1061_CR101","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00467-023-06096-5","volume":"39","author":"O Salehi","year":"2024","unstructured":"Salehi, O., Mack, H., Colville, D., Lewis, D. & Savige, J. Ocular manifestations of renal ciliopathies. Pediatr. Nephrol. 39, 1327\u20131346 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR102","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00467-023-06073-y","volume":"39","author":"V Zhu","year":"2024","unstructured":"Zhu, V. et al. Ocular manifestations of the genetic causes of focal and segmental glomerulosclerosis. Pediatr. Nephrol. 39, 655\u2013679 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"1061_CR103","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41581-025-00970-1","volume":"21","author":"I Bensouna","year":"2025","unstructured":"Bensouna, I. et al. Nephrogenomics, precision medicine and the role of genetic testing in adult kidney disease management. Nat. Rev. Nephrol. 21, 597\u2013612 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"1061_CR104","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10157-015-1197-9","volume":"20","author":"XJ Fu","year":"2016","unstructured":"Fu, X. J. et al. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene. Clin. Exp. Nephrol. 20, 699\u2013702 (2016).","journal-title":"Clin. Exp. Nephrol."},{"key":"1061_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.838983","volume":"9","author":"H Deng","year":"2022","unstructured":"Deng, H., Zhang, Y., Ding, J. & Wang, F. Presumed COL4A3\/COL4A4 missense\/synonymous variants induce aberrant splicing. Front. Med. 9, 838983 (2022).","journal-title":"Front. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01061-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:02:34Z","timestamp":1782129754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01061-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":105,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01061-5","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"9 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}